You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

progressive pulmonary fibrosis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Progressive Pulmonary Fibrosis, Interstitial Lung Disease Trial (Placebo, Inhaled Treprostinil, Treprostinil Ultrasonic

Not yet recruiting
  • Progressive Pulmonary Fibrosis
  • Interstitial Lung Disease
  • Placebo
  • +2 more
  • (no location specified)
Jul 5, 2023

Risk Factors in Progressive Pulmonary Fibrosis

Not yet recruiting
  • Interstitial Lung Disease
    • (no location specified)
    Jun 7, 2023

    Progressive Pulmonary Fibrosis Trial in Worldwide (BMS-986278, BMS-986278 Placebo)

    Not yet recruiting
    • Progressive Pulmonary Fibrosis
    • Stanford, California
    • +7 more
    Sep 11, 2023

    Progressive Fibrosing Interstitial Lung Disease

    Completed
    • Lung Diseases, Interstitial
      • Ridgefield, Connecticut
        Boehringer Ingelheim Pharmaceuticals, Inc.
      May 16, 2023

      Interstitial Lung Diseases Trial in Wenzhou (Anlotinib, Placebo)

      Recruiting
      • Interstitial Lung Diseases
      • Wenzhou, Zhejiang, China
        The First Affiliated Hospital of Wenzhou Medical University
      Apr 13, 2023

      Progressive Idiopathic Pulmonary Fibrosis Trial in France (pirfenidone and nintedanib, pirfenidone or nintedanib)

      Recruiting
      • Progressive Idiopathic Pulmonary Fibrosis
      • pirfenidone and nintedanib
      • pirfenidone or nintedanib
      • Angers, France
      • +15 more
      Jan 20, 2022

      INCHANGE - Nintedanib for Changes in Cough and Dyspnea in

      Not yet recruiting
      • Lung Diseases, Interstitial
      • (no location specified)
      Aug 19, 2022

      Progressive Fibrosing Interstitial Lung Disease, Lung Transplant, Cystic Fibrosis Trial in Edmonton (ADAMM- RSM Device)

      Recruiting
      • Progressive Fibrosing Interstitial Lung Disease
      • +4 more
      • ADAMM- RSM Device
      • Edmonton, Alberta, Canada
        University of Alberta
      Dec 1, 2022

      Systemic Sclerosis, Scleroderma, Diffuse Systemic Sclerosis Trial in Scottsdale (Ixazomib)

      Recruiting
      • Systemic Sclerosis
      • +18 more
      • Scottsdale, Arizona
        Mayo Clinic in Arizona
      May 3, 2022

      Lung Diseases, Interstitial Trial in China (nintedanib, Placebo)

      Recruiting
      • Lung Diseases, Interstitial
      • Beijing, China
      • +15 more
      Jan 23, 2023

      Silicosis, Progressive Massive Fibrosis, Complicated Silicosis Trial in Cadiz (Pirfenidone Oral Tablet)

      Recruiting
      • Silicosis
      • +2 more
      • Pirfenidone Oral Tablet
      • Cadiz, Spain
        Antonio León Jiménez
      Dec 27, 2021

      Fibrosing ILD Biomarkers That Rule Acceleration

      Recruiting
      • Pulmonary Fibrosis
      • Sarcoidosis
      • Comprehensive clinical assessment and biological samples collection
      • Porto, Portugal
        Centro Hospitalar Universitário São João
      Jan 12, 2023

      INREAL - Nintedanib for Changes in Dyspnea and Cough in Patients

      Recruiting
      • Lung Diseases, Interstitial
      • Aachen, Germany
      • +19 more
      Jul 26, 2022

      Idiopathic Pulmonary Fibrosis Trial in Assiut (Azithromycin, Methylprednisolone)

      Not yet recruiting
      • Idiopathic Pulmonary Fibrosis
      • Assiut, Egypt
        Assiut university-Faculty of Medicine
      May 2, 2023

      Idiopathic Pulmonary Fibrosis Trial in Hialeah Gardens (20mM sodium pyruvate nasal spray, Saline Placebo control nasal spray)

      Recruiting
      • Idiopathic Pulmonary Fibrosis
      • 20mM sodium pyruvate nasal spray
      • Saline Placebo control nasal spray
      • Hialeah Gardens, Florida
        Family First Medical Research Center
      Sep 16, 2023

      Lung Diseases, Interstitial Trial in Belgium (nintedanib)

      Available
      • Lung Diseases, Interstitial
      • Aalst, Belgium
      • +13 more
      Aug 8, 2022

      Idiopathic Pulmonary Fibrosis Trial (TDI01 suspension)

      Not yet recruiting
      • Idiopathic Pulmonary Fibrosis
      • TDI01 suspension
      • (no location specified)
      Oct 30, 2023

      Idiopathic Pulmonary Fibrosis, Activity, Motor Trial (Activities of Daily Living Protocol)

      Not yet recruiting
      • Idiopathic Pulmonary Fibrosis
      • Activity, Motor
      • Activities of Daily Living Protocol
      • (no location specified)
      Sep 21, 2023

      Idiopathic Pulmonary Fibrosis Trial in Los Angeles (Atezolizumab)

      Not yet recruiting
      • Idiopathic Pulmonary Fibrosis
      • Los Angeles, California
        Cedars-Sinai Medical Center
      Aug 23, 2022

      Idiopathic Pulmonary Fibrosis Trial in Shanghai (Cell Free Fat Extract(CEFFE))

      Recruiting
      • Idiopathic Pulmonary Fibrosis
      • Cell Free Fat Extract(CEFFE)
      • Shanghai, Shanghai, China
        The Ninth People's Hospital Affiliated to Shanghai Jiao Tong Uni
      May 22, 2023

      Idiopathic Pulmonary Fibrosis Trial in Birmingham (Venetoclax)

      Not yet recruiting
      • Idiopathic Pulmonary Fibrosis
      • Birmingham, Alabama
        A. Brent Carter
      Aug 3, 2023

      Pulmonary Fibrosis Trial in Beijing (99mTc-HFAPI)

      Recruiting
      • Pulmonary Fibrosis
      • Beijing, Dongcheng, China
        Peking union medical college hospital
      May 5, 2023

      Heart Rate Variability and Nocturnal Blood Oxygen Saturation in

      Recruiting
      • Idiopathic Pulmonary Fibrosis
      • "LARGAN" ECG Holter
      • Taipei, Taiwan
        Taipei Veterans General Hospital
      Sep 6, 2023

      Experiences of Pulmonary Fibrosis Patients

      Not yet recruiting
      • Pulmonary Fibrosis
        • San Francisco, California
          Power Life Sciences
        Jun 2, 2023

        Idiopathic Pulmonary Fibrosis Trial in Rome (Autologous FMT, Placebo FMT)

        Not yet recruiting
        • Idiopathic Pulmonary Fibrosis
        • Autologous FMT
        • Placebo FMT
        • Rome, Roma, Italy
          Fondazione Policlinico Agostino Gemelli IRCCS
        Feb 23, 2023